Sec. 1. Short title; table of contents

296 words·~1 min read·/bill/116/hr/3/rh/section-1

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

This Act may be cited as the . Lower Drug Costs Now Act of 2019 The table of contents is as follows: Sec. 1. Short title; table of contents. Title I—Lowering Prices Through Fair Drug Price Negotiation Sec. 101. Providing for lower prices for certain high-priced single source drugs. Sec. 102. Selected drug manufacturer excise tax imposed during noncompliance periods. Title II—Medicare Parts B and D Prescription Drug Inflation Rebates Sec. 201. Medicare part B rebate by manufacturers.

Sec. 202. Medicare part D rebate by manufacturers. Title III—Part D Improvements and Maximum Out-of-Pocket Cap for Medicare Beneficiaries Sec. 301. Medicare part D benefit redesign. Sec. 302. Allowing certain enrollees of prescription drugs plans and MA–PD plans under Medicare program to spread out cost-sharing under certain circumstances. Sec. 303. Establishment of pharmacy quality measures under Medicare part D. Title IV—Prescription Drug Policies for Low-Income Individuals Sec. 401.

Adjustments to Medicare part D cost-sharing reductions for low-income individuals. Sec. 402. Dissemination to Medicare part D subsidy eligible individuals of information comparing premiums of certain prescription drug plans. Sec. 403. Providing for intelligent assignment of certain subsidy eligible individuals auto-enrolled under Medicare prescription drug plans and MA–PD plans. Sec. 404. Expanding eligibility for low-income subsidies under part D of the Medicare program. Sec. 405.

Automatic eligibility of certain low-income territorial residents for premium and cost-sharing subsidies under the Medicare program; Sunset of enhanced allotment program. Sec. 406. Automatic qualification of certain Medicaid beneficiaries for premium and cost-sharing subsidies under part D of the Medicare program. Sec. 407. Eliminating the resource requirement with respect to subsidy eligible individuals under part D of the Medicare program. Title V—Drug Price Transparency Sec. 501.

Drug price transparency. Title VI—Miscellaneous Sec. 601. Temporary increase in Medicare part B payment for certain biosimilar biological products.